Collagen Corp. (NASDAQ:CGEN) said that an Illinois woman hasvoluntarily dropped a lawsuit against the company in whichshe claimed that injectable collagen treatments caused her todevelop scleroderma. The Palo Alto, Calif., company alsoannounced that a federal court in Texas has denied a motionfor a new trial brought by a woman who had alleged thatcollagen injections caused her to develop a rare autoimmunedisease. The Texas court ruled in October that her claims werepreempted by Medical Device Amendments to the Food, Drugand Cosmetic Act. The stock closed unchanged at $24.

(c) 1997 American Health Consultants. All rights reserved.